Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Successful treatment of refractory anterior scleritis in primary Sjogren's syndrome with rituximab.

Literature DB >> 15958765

Successful treatment of refractory anterior scleritis in primary Sjogren's syndrome with rituximab.

K Ahmadi-Simab, P Lamprecht, B Nölle, M Ai, W L Gross.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2005 PMID： 15958765 PMCID： PMC1755562 DOI： 10.1136/ard.2004.027128

Source DB: PubMed Journal: Ann Rheum Dis ISSN： 0003-4967 Impact factor: 19.103

Keyword Cloud
Cited

× No keyword cloud information.

22 in total

Review 1. Anti-inflammatory treatment of uveitis with biologicals: new treatment options that reflect pathogenetic knowledge of the disease.

Authors: Arnd Heiligenhaus; Stephan Thurau; Maren Hennig; Rafael S Grajewski; Gerhild Wildner
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2010-08-25 Impact factor: 3.117

Review 2. Biologic therapy for refractory scleritis: a new treatment perspective.

Authors: Tania Sales de Alencar de Fidelix; Luis Antonio Vieira; Denise de Freitas; Virginia Fernandes Moça Trevisani
Journal: Int Ophthalmol Date: 2015-08-29 Impact factor: 2.031

Review 3. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007.

Authors: D E Furst; F C Breedveld; J R Kalden; J S Smolen; G R Burmester; J Sieper; P Emery; E C Keystone; M H Schiff; P Mease; P L C M van Riel; R Fleischmann; M H Weisman; M E Weinblatt
Journal: Ann Rheum Dis Date: 2007-11 Impact factor: 19.103

Review 4. Biologic agents in the management of inflammatory eye diseases.

Authors: Kira Michalova; Lyndell Lim
Journal: Curr Allergy Asthma Rep Date: 2008-07 Impact factor: 4.806

5. A case of necrotizing keratoscleritis in primary Sjogren's syndrome.

Authors: Won Choi; Shin-Seok Lee; Yeong-Geol Park; Kyung-Chul Yoon
Journal: Korean J Ophthalmol Date: 2011-07-22

6. Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjögren's syndrome.

Authors: Raphaèle Seror; Christelle Sordet; Loic Guillevin; Eric Hachulla; Charles Masson; Marc Ittah; Sophie Candon; Véronique Le Guern; Achille Aouba; Jean Sibilia; Jacques-Eric Gottenberg; Xavier Mariette
Journal: Ann Rheum Dis Date: 2006-09-01 Impact factor: 19.103

Successful treatment of refractory anterior scleritis in primary Sjogren's syndrome with rituximab.

Review 1. Anti-inflammatory treatment of uveitis with biologicals: new treatment options that reflect pathogenetic knowledge of the disease.

Review 2. Biologic therapy for refractory scleritis: a new treatment perspective.

Review 3. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007.

Review 4. Biologic agents in the management of inflammatory eye diseases.

5. A case of necrotizing keratoscleritis in primary Sjogren's syndrome.

6. Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjögren's syndrome.

Review 7. Pharmacotherapy of scleritis: current paradigms and future directions.

8. Necrotising scleritis and connective tissue disease--three cases and a review.

Review 9. Scleritis and peripheral ulcerative keratitis.

Review 10. Sjögren's Syndrome: More Than Just Dry Eye.